These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 31023357)

  • 1. Clinical experience with tigecycline in the treatment of hospital-acquired pneumonia caused by multidrug resistant Acinetobacter baumannii.
    Zhou Y; Chen X; Xu P; Zhu Y; Wang K; Xiang D; Wang F; Banh HL
    BMC Pharmacol Toxicol; 2019 Apr; 20(1):19. PubMed ID: 31023357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes and prognostic factors of tigecycline treatment for hospital-acquired pneumonia involving multidrug-resistant
    Liu B; Li S; Li HT; Wang X; Tan HY; Liu S; Pan PH; Li XG; Li XM
    J Int Med Res; 2020 Apr; 48(4):300060520910917. PubMed ID: 32339001
    [No Abstract]   [Full Text] [Related]  

  • 3. The clinical implication and prognostic predictors of tigecycline treatment for pneumonia involving multidrug-resistant Acinetobacter baumannii.
    Ye JJ; Lin HS; Kuo AJ; Leu HS; Chiang PC; Huang CT; Lee MH
    J Infect; 2011 Nov; 63(5):351-61. PubMed ID: 21846481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes of tigecycline in the treatment of multidrug-resistant Acinetobacter baumannii infection.
    Shin JA; Chang YS; Kim HJ; Kim SK; Chang J; Ahn CM; Byun MK
    Yonsei Med J; 2012 Sep; 53(5):974-84. PubMed ID: 22869481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effectiveness of tigecycline-based versus colistin- based therapy for treatment of pneumonia caused by multidrug-resistant Acinetobacter baumannii in a critical setting: a matched cohort analysis.
    Chuang YC; Cheng CY; Sheng WH; Sun HY; Wang JT; Chen YC; Chang SC
    BMC Infect Dis; 2014 Feb; 14():102. PubMed ID: 24564226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of tigecycline in treatment of pneumonia caused by MDR Acinetobacter baumannii: a systematic review and meta-analysis.
    Mei H; Yang T; Wang J; Wang R; Cai Y
    J Antimicrob Chemother; 2019 Dec; 74(12):3423-3431. PubMed ID: 31377765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Observation of clinical efficacy of the cefoperazone/sulbactam anti-infective regimen in the treatment of multidrug-resistant Acinetobacter baumannii lung infection.
    Wang Q; Huang M; Zhou S
    J Clin Pharm Ther; 2022 Jul; 47(7):1020-1027. PubMed ID: 35285526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
    PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical outcomes of tigecycline alone or in combination with other antimicrobial agents for the treatment of patients with healthcare-associated multidrug-resistant Acinetobacter baumannii infections.
    Lee YT; Tsao SM; Hsueh PR
    Eur J Clin Microbiol Infect Dis; 2013 Sep; 32(9):1211-20. PubMed ID: 23553594
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical experience with tigecycline as treatment for serious infections in elderly and critically ill patients.
    Kuo SC; Wang FD; Fung CP; Chen LY; Chen SJ; Chiang MC; Hsu SF; Liu CY
    J Microbiol Immunol Infect; 2011 Feb; 44(1):45-51. PubMed ID: 21531352
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preliminary experience with tigecycline treatment for severe infection in children.
    Ye S; Zhang C; Lin S
    Eur J Pediatr; 2018 Oct; 177(10):1489-1496. PubMed ID: 30008076
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
    Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
    Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
    Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
    J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sources of multidrug-resistant Acinetobacter baumannii and its role in respiratory tract colonization and nosocomial pneumonia in intensive care unit patients.
    Huang J; Chen EZ; Qu HP; Mao EQ; Zhu ZG; Ni YX; Han LZ; Tang YQ
    Chin Med J (Engl); 2013; 126(10):1826-31. PubMed ID: 23673094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early experience with tigecycline for ventilator-associated pneumonia and bacteremia caused by multidrug-resistant Acinetobacter baumannii.
    Schafer JJ; Goff DA; Stevenson KB; Mangino JE
    Pharmacotherapy; 2007 Jul; 27(7):980-7. PubMed ID: 17594203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is tigecyclin a good choice in the treatment of multidrug-resistant Acinetobacter baumannii pneumonia?
    Tasbakan MS; Pullukcu H; Sipahi OR; Tasbakan MI; Aydemir S; Bacakoglu F
    J Chemother; 2011 Dec; 23(6):345-9. PubMed ID: 22233818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical experience with tigecycline in the treatment of carbapenem-resistant Acinetobacter infections.
    Metan G; Alp E; Yildiz O; Percin D; Aygen B; Sumerkan B
    J Chemother; 2010 Apr; 22(2):110-4. PubMed ID: 20435570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tigecycline-based versus sulbactam-based treatment for pneumonia involving multidrug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Ye JJ; Lin HS; Yeh CF; Wu YM; Huang PY; Yang CC; Huang CT; Lee MH
    BMC Infect Dis; 2016 Aug; 16():374. PubMed ID: 27496018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influencing factors of successful eradication of multidrug-resistant Acinetobacter baumannii in the respiratory tract with aerosolized colistin.
    Chen YM; Fang WF; Kao HC; Chen HC; Tsai YC; Shen LS; Li CL; Chang HC; Huang KT; Lin MC; Wang CC; Chao TY
    Biomed J; 2014; 37(5):314-20. PubMed ID: 25179700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of tigecycline in combination with cefoperazone-sulbactam against multidrug-resistant Acinetobacter baumannii.
    Liu B; Bai Y; Liu Y; Di X; Zhang X; Wang R; Wang J
    J Chemother; 2015 Oct; 27(5):271-6. PubMed ID: 25068186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.